Sign In
Home
Abiraterone - Abiraterone Acetate tablet
Get your patient on
Abiraterone - Abiraterone Acetate tablet
(Abiraterone Acetate)
250 mg Tab
Check coverage
See the specific documentation and step therapies required.
Check coverage
Check drug interactions
See all drug-to-drug interactions for this medication.
Check drug interactions (27 major)
Prescribing info
PubMed™ news
Abiraterone - Abiraterone Acetate tablet prescribing information
Data source
Data source
Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as changes are made available
Report Adverse Event
Check medication interactions
Review interactions as part of your prescribing workflow
Check interactions
Abiraterone - Abiraterone Acetate tablet PubMed™ news
Last year
Publication date
Article Type
Format
5 articles
Reset Filters
5 most recent articles for Abiraterone - Abiraterone Acetate tablet
,
view all articles on PubMed™
Journal Article • 2026 Jun
Polypharmacy and clinical outcomes in geriatric patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor pathway inhibitors.
Journal Article • 2026 Jun
Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy.
Journal Article • 2026 Jun
Pharmacokinetics, safety, and efficacy of fuzuloparib in combination with abiraterone acetate and prednisone in patients with metastatic castration-resistant prostate cancer: a phase 1 dose escalation and expansion study.
Journal Article • 2026 Jun
Darolutamide versus abiraterone acetate-based triplets in patients with hormone-sensitive prostate cancer: real-world, head-to-head comparison from the ARON-3 study.
Journal Article • 2026 Jun
Enzalutamide Versus Abiraterone After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Real-World Outcomes and Exploratory Prognostic Stratification.
Show the latest PubMed™ articles for Abiraterone - Abiraterone Acetate tablet
I certify that I'm a U.S. healthcare provider
